CELU Celularity Inc
Healthcare · Market cap: $20.4M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $155.2K | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $1.5M | $0 |
| 2023-Q4 | $1.5M | $0 |
| 2024-Q1 | $5.4M | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$8.5M6 buy days
Sold$00 sell days
Net insider flow+$8.5Mnet buying · 5 years
Latest trade2024-01-12Lim Kok Thay
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2024-01-12 | Buy | Lim Kok Thay | 10% owner | 21,410,983 | $0.25 | $5.4M | 1 |
| 2023-10-05 | Buy | Hariri Robert J | CEO | 9,357,585 | $0.16 | $1.5M | 2 |
| 2023-09-29 | Buy | Hariri Robert J | CEO | 9,064,539 | $0.17 | $1.5M | 1 |
| 2022-11-30 | Buy | Hariri Robert J | CEO | 10,000 | $1.72 | $17.2K | 1 |
| 2022-11-29 | Buy | Hariri Robert J | CEO | 40,000 | $1.71 | $68.4K | 1 |
| 2022-11-28 | Buy | Hariri Robert J | CEO | 40,000 | $1.74 | $69.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Lim Kok Thay | 10% owner | $5.4M | $0 | 2024-01-12 |
| Hariri Robert J | CEO | $3.2M | $0 | 2023-10-05 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.